Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog® in Japanese patients with type 1 diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes Investigation"
DOI: 10.1111/jdi.13195
Abstract: Ultra‐rapid lispro (URLi) is a novel ultra‐rapid mealtime insulin. This study compared the pharmacokinetic and glucodynamic profiles, safety, and tolerability of URLi and lispro (Humalog®) in Japanese patients with type 1 diabetes mellitus. read more here.
Keywords: ultra rapid; patients type; humalog japanese; japanese patients ... See more keywords
Adjusting Therapy Profiles When Switching to Ultra-Rapid Lispro in an Advanced Hybrid Closed-Loop System: An in Silico Study.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of diabetes science and technology"
DOI: 10.1177/19322968221140401
Abstract: BACKGROUND It has been shown that insulin acceleration by itself might not be sufficient to see clear improvements in glycemic metrics, and insulin therapy may need to be adjusted to fully leverage the extra safety… read more here.
Keywords: rapid lispro; system; adjusting therapy; therapy ... See more keywords
232-OR: Long-Term Safety and Efficacy of Ultra-Rapid Lispro (URLi) in PRONTO-T1D
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-232-or
Abstract: PRONTO T1D was a phase 3 study evaluating ultra rapid lispro (URLi) in adults with type 1 diabetes (T1D) for 52 weeks. Subjects were randomized to double-blind mealtime URLi, Humalog, or open-label postmeal URLi with… read more here.
Keywords: ultra rapid; long term; pronto t1d; lispro urli ... See more keywords
Efficacy and Safety of Ultra-Rapid Lispro Versus Lispro in Patients with Type 1 and 2 Diabetes: Indian Subpopulation Analyses of the PRONTO-T1D and PRONTO-T2D Trials
Sign Up to like & getrecommendations! Published in 2022 at "Indian Journal of Endocrinology and Metabolism"
DOI: 10.4103/ijem.ijem_459_21
Abstract: 186 Sir, Although advances have been made in the treatment of both type 1 and 2 diabetes, many patients still do not achieve sufficient glycaemic control.[1] The reasons behind this are multifactorial, but post‐prandial hyperglycaemia… read more here.
Keywords: patients type; rapid lispro; t1d pronto; type diabetes ... See more keywords